| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Investments, at fair value-Investment Unaffiliated Issuer | 1,487,246 | - | ||
| Investments, at fair value-Investment Affiliated Issuer Noncontrolled | 30,476 | - | ||
| Investments, at fair value-Investment Affiliated Issuer Controlled | 62,956 | - | ||
| Cash and cash equivalents | 5,786 | - | ||
| Restricted cash and cash equivalents | 22,017 | - | ||
| Interest and dividend receivable | 9,932 | - | ||
| Receivable from unsettled transactions | 5,285 | - | ||
| Unrealized appreciation on foreign currency forward contracts | 2,082 | - | ||
| Deferred tax assets | 181 | - | ||
| Other assets | 1,667 | - | ||
| Total assets | 1,627,628 | - | ||
| Debt (net of deferred financing costs of 6,448 and 8,214, respectively) | 875,315 | 887,318 | ||
| Distributions payable | 15,557 | 15,566 | ||
| Interest and other debt financing costs payable | 7,943 | 12,479 | ||
| Management fees payable | 5,119 | 5,075 | ||
| Incentive fees payable | 3,574 | 3,557 | ||
| Deferred tax liabilities | 181 | 223 | ||
| Unrealized depreciation on foreign currency forward contracts | 2,271 | 2,606 | ||
| Accrued expenses and other liabilities | 3,593 | 2,904 | ||
| Total liabilities | 913,553 | 929,728 | ||
| Common stock, par value 0.001 per share (200,000,000 shares authorized, 37,039,657 and 37,061,547 shares issued and outstanding, respectively) | 37 | 37 | ||
| Paid-in capital in excess of par value | 958,765 | 959,098 | ||
| Accumulated earnings (loss) | -244,727 | -234,419 | ||
| Total net assets | 714,075 | 724,716 | ||
| Total liabilities and net assets | 1,627,628 | 1,654,444 | ||
Crescent Capital BDC, Inc. (CCAP)
Crescent Capital BDC, Inc. (CCAP)